Redoxis AB
556726-4451ActiveSwedish CRO specializing in preclinical autoimmune and inflammatory disease models.
Contract Research Organization (CRO)redoxis.com
Översikt
- 19
- Anställda
- 28.6milj SEK
- Omsättning
- 2007
- Grundat
Nyckelbeslutsfattare
Malin Hultqvist
Chief Executive Officer
@redoxis.com+46707XXXXXX
Nina Woodworth
Chief Operating Officer
@redoxis.com+46760XXXXXX
Caroline Alkner
Head of In Vitro
@redoxis.com
Anita Tollstadius
Board Member
@redoxis.com
+29 fler kontakter i Funnelfeedr
Beskrivning
Redoxis is a specialized Swedish Contract Research Organization (CRO) founded in 2007. Their core expertise lies in preclinical drug development and the efficacy evaluation of novel therapies targeting inflammatory and autoimmune diseases. They offer a comprehensive portfolio of services, including...